Award recordCONTRACT

TEVA PHARMACEUTICALS USA, INC.

PIID VA797E17C0034· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $0 net obligations· UEI NEN9A34LRHJ5· PA

Description

INCORPORATING 2022 SUBK PLAN.

Base award description: ALBUTEROL SO4 90MCG/ACTUAT (CFC-F) INHALER, ORAL 200 DOSES WITH DOSE COUNTER AWARDED TO TEVA EFFECTIVE 28 JULY 2017 - 27 JULY 2018 PLUS FOUR ONE YEAR OPTION YEARS

First action · last action
2017-05-16 · 2022-01-25
Transactions
12
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,869,166,599
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2017-05-16 · this action $0 · running total $0Modification P00001 · 2017-12-18 · this action $0 · running total $0Modification P00002 · 2018-06-19 · this action $0 · running total $0Modification P00003 · 2019-01-24 · this action $0 · running total $0Modification P00004 · 2019-06-05 · this action $0 · running total $0Modification P00005 · 2020-01-15 · this action $0 · running total $0Modification P00006 · 2020-06-16 · this action $0 · running total $0Modification P00007 · 2020-12-09 · this action $0 · running total $0Modification P00008 · 2020-12-17 · this action $0 · running total $0Modification P00009 · 2021-06-22 · this action $0 · running total $0Modification P00010 · 2021-12-29 · this action $0 · running total $0Modification P00011 · 2022-01-25 · this action $0 · running total $0
  • Base2017-05-16+$0= $0
  • Mod P000012017-12-18+$0= $0
  • Mod P000022018-06-19+$0= $0
  • Mod P000032019-01-24+$0= $0
  • Mod P000042019-06-05+$0= $0
  • Mod P000052020-01-15+$0= $0
  • Mod P000062020-06-16+$0= $0
  • Mod P000072020-12-09+$0= $0
  • Mod P000082020-12-17+$0= $0
  • Mod P000092021-06-22+$0= $0
  • Mod P000102021-12-29+$0= $0
  • Mod P000112022-01-25+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-05-16+$0$0ALBUTEROL SO4 90MCG/ACTUAT (CFC-F) INHALER, ORAL 200 DOSES WITH DOSE COUNTER AWARDED TO TEVA EFFECTIVE 28 JUL…
Mod P00001· ADD SUBCONTRACTING PLAN2017-12-18+$0$0INCORPORATION OF 2018 APPROVED SUBCONTRACTING PLAN.
Mod P00002· EXERCISE AN OPTION2018-06-19+$0$0EXERCISE OPTION YEAR 1 FOR ALBUTEROL 200 DOSE INHALER.
Mod P00003· ADD SUBCONTRACTING PLAN2019-01-24+$0$0INCORPORATE SUBK PLAN FOR ALBUTEROL 200 DOSE INHALER THROUGH 12/31/2019.
Mod P00004· EXERCISE AN OPTION2019-06-05+$0$0EXERCISING 2ND OPTION YEAR FOR FOR ALBUTEROL 200 DOSE INHALER THROUGH 7/27/2020 WITH PRICE CHANGES
Mod P00005· ADD SUBCONTRACTING PLAN2020-01-15+$0$0INCORPORATE 2020 SUBCONTRACTING PLAN
Mod P00006· EXERCISE AN OPTION2020-06-16+$0$0EXERCISE 3RD OPTION YEAR WITH PRICE CHANGES.
Mod P00007· OTHER ADMINISTRATIVE ACTION2020-12-09+$0$0THE AWARDED NATIONAL CONTRACT PRICES UNDER THE CONTRACT REMAIN BELOW THE FCPS FOR 2021.
Mod P00008· ADD SUBCONTRACTING PLAN2020-12-17+$0$0THIS MODIFICATION IS ISSUED TO INCORPORATE THE APPROVED COMMERCIAL-WIDE SUBCONTRACTING PLAN INTO THE ABOVE REF…
Mod P00009· EXERCISE AN OPTION2021-06-22+$0$0THIS MODIFICATION IS ISSUED TO EXERCISE THE 4TH AND FINAL OPTION YEAR FOR CONTRACT VA797E-17-C-0034, 7/28/2021…
Mod P00010· OTHER ADMINISTRATIVE ACTION2021-12-29+$0$0INCORPORATING 2022 FEDERAL CEILING PRICES
Mod P00011· ADD SUBCONTRACTING PLAN2022-01-25+$0$0INCORPORATING 2022 SUBK PLAN.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NEN9A34LRHJ5)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0125NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79723D0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79722D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA797E17A0007NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2018
V797D70217NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017
VA797E17C0033NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797E17C0034_3600 · retrieved 2026-09-26.